Earth Science Tech, Inc. (OTC: ETST) has announced its fiscal first-quarter 2027 financial results, revealing a 57% year-over-year increase in net income to $715,697. The company's revenue reached $9.0 million, up 3% from the prior-year period, while gross profit climbed to $6.3 million. Operating cash flow more than doubled to $707,131, and total assets grew to $10.4 million. Diluted earnings per share improved to $0.003 from $0.001, and the company repurchased and retired more than 3.7 million common shares during the quarter without incurring additional debt.
These results underscore Earth Science Tech's operational efficiency and its ability to generate substantial profitability despite modest revenue growth. The significant increase in net income and operating cash flow indicates improved margins and cost management, which are critical for sustaining long-term growth. The company's decision to repurchase shares without adding debt also signals confidence in its financial stability and commitment to enhancing shareholder value.
All key operating subsidiaries remained profitable during the quarter, according to the company. Earth Science Tech continues to expand the licensing footprint of its compounding pharmacy operations across the United States, while also evaluating opportunities to broaden its telehealth and pharmacy fulfillment platforms. This strategic focus on vertical integration and expansion is designed to strengthen its position in the health and wellness sector.
Management will discuss these results and strategic initiatives at the annual shareholder meeting scheduled for Aug. 31, 2026. Investors will vote on proposals including the cancellation of the company's Series B Preferred Stock and will hear updates on a potential exchange uplisting aimed at improving liquidity and market visibility. The uplisting could enhance the company's access to capital markets and attract a broader investor base, potentially increasing trading liquidity and overall market recognition.
The company's diversified holding structure, which includes compounding pharmacy, telemedicine, and direct-to-patient fulfillment, positions it to capitalize on the growing demand for integrated healthcare solutions. By combining these services, Earth Science Tech aims to streamline patient care from consultation to delivery, offering a seamless experience that could drive customer loyalty and recurring revenue.
For more information, visit the company's newsroom at https://ibn.fm/ETST.
